Comparison of Pruritus Incidence After Intrathecal Morphine 0.1 vs 0.2 mg in Cesarean Section

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorKhon Kaen University

About this trial

This study compares the incidence of pruritus (itching) requiring treatment between two doses of intrathecal morphine (0.1 mg vs 0.2 mg) when used for spinal anesthesia during cesarean section. The study aims to determine if the lower dose (0.1 mg) can reduce pruritus incidence while maintaining adequate pain relief.

Eligibility criteria

Qualifiers

Full-term pregnancy

Scheduled for non-emergency cesarean section

ASA physical status I-III

Non-complicated pregnancy

Disqualifiers

Contraindication to spinal anesthesia or study drugs

Refusal to participate in the study

BMI ≥ 40 kg/m²

History of systemic skin disease or current itchy skin condition

Trial design

Treatments tested in this trial

  • Morphine Sulfate

Treatment groups

69 Participants
are divided into 2 treatment groups

Sponsors and collaborators